|
HS Code |
292821 |
| Chemical Formula | C9H6N2O2S |
| Molecular Weight | 206.22 g/mol |
| Appearance | Solid (usually a powder) |
| Physical State At Room Temperature | Solid |
| Melting Point | Data required from reliable source |
| Boiling Point | Data required from reliable source |
| Solubility In Water | Poorly soluble (estimate based on structure) |
| Solubility In Organic Solvents | Likely soluble in common organic solvents like DMSO, acetone |
| Density | Data required from reliable source |
| Odor | Odor data required from reliable source |
As an accredited 2-Cyano-6-Methoxybenzothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of 2 - Cyano - 6 - Methoxybenzothiazole packaged in a sealed, chemical - resistant bag. |
| Shipping | 2 - Cyano - 6 - Methoxybenzothiazole is shipped in well - sealed, corrosion - resistant containers. Packaging adheres to chemical transport regulations. Shipment is via approved carriers, ensuring proper handling to prevent damage and leakage during transit. |
| Storage | 2 - Cyano - 6 - methoxybenzothiazole should be stored in a cool, dry, well - ventilated area. Keep it away from heat sources, open flames, and incompatible substances such as strong acids and bases. Store in a tightly sealed container to prevent moisture absorption and potential reactions. Avoid storing near oxidizing agents. |
|
` Produced via a catalytic cyanohydrin cascade or sourced as an isolated intermediate with a nominal purity exceeding 99.2% (HPLC, area%), 2-cyano-6-methoxybenzothiazole enters the optical brightener value chain as a precursor to asymmetrical bis(benzoxazolyl) stilbene-type derivatives. Unlike conventional sulfonated distyrylbiphenyls, the introduction of the cyano and methoxy substituents onto a benzothiazole backbone shifts the absorption maximum into the near-UV boundary and narrows the emission band, a requirement for high-whiteness polyester staple fibre where a blue cast is undesirable under the CIE D65 illuminant. In a typical masterbatch formulation for PET fibre spinning at an intrinsic viscosity of 0.65 dL/g, the precursor is condensed with an aminophenol derivative in polyphosphoric acid at 180–190 °C under a nitrogen sweep for 6–8 hours, yielding a cyano-methoxy-substituted bis-benzoxazole with a melting point exceeding 320 °C. The intermediate must be milled to a particle size distribution with d90 ≤ 2 µm prior to let-down into a PET carrier resin on a co-rotating twin-screw extruder operating at an L/D ratio of 40:1 and a screw speed capped at 250 rpm to limit viscous heat rise. Localized overheating above 330 °C within dead spots in the melt line triggers premature thermal cleavage of the cyano group, generating a tan chromophore that depresses the CIE Whiteness Index (ASTM E313-20) by 8–12 points and forces the batch into off-spec regrind. The let-down ratio is maintained at 1.5 % by weight for a final brightener concentration of 250–300 ppm in the drawn fibre, a window validated on a continuous polycondensation line with a throughput of 120 tonnes per day. Downstream, fabric mill trials following ISO 105-B02:2014 have confirmed that lightfastness degrades sharply when the cyano equivalent exceeds 0.45 mol% of the brightener active, due to triplet-state oxygen sensitization, limiting the formulation to indoor apparel and bedding textiles. How Does the Nitrile Handle Participation in Thiazole Ring Alkylation Govern Reactivity Toward C-2 Amination?Synthesis of 2-substituted thioether and amine pharmacophores for veterinary anthelmintics exploits the electron-withdrawing effect of the cyano group at the 2-position of the benzothiazole nucleus, which activates the thiazole carbon toward nucleophilic displacement under mild alkaline conditions. In a manufacturing campaign for a benzimidazole-thiazole hybrid intended as a fasciolicide, 2-cyano-6-methoxybenzothiazole is dissolved in anhydrous DMF (Karl Fischer ≤ 100 ppm H₂O) and treated with a secondary amine—pyrrolidine or a substituted piperazine—at a molar ratio of 1:1.05 in the presence of anhydrous potassium carbonate (1.2 eq.) at 50–55 °C for 4 hours. The process, conducted in a glass-lined reactor under an inert atmosphere, is highly exothermic upon initial amine addition; the dosing rate is slaved to the jacket inlet temperature and must never exceed a reaction mass temperature ramp of 2 °C/min to avoid a runaway cyanide displacement that generates toxic hydrogen cyanide gas. Quenching with controlled pH 4.5–5.0 acetate buffer precipitates the 2-aminated product, which is isolated via a pressure filter with a PTFE membrane cloth and dried under vacuum at 55 °C to a residual DMF level below 0.1 %, as determined by headspace GC-FID. The resulting advanced intermediate carries a residual cyano functionality that is subsequently reduced to an aminomethyl or formamide moiety in a separate hydrogenation loop; the regulatory file, structured per VICH GL18 (Residue Studies) and VICH GL37 (Analytical Method Validation), requires that the benzothiazole-related substance at RRT 1.35 does not exceed 0.10 % in the drug substance. A critical operational boundary exists in the form of the methoxy group susceptibility to demethylation by Lewis acid catalysts should the amination step be accelerated with a zinc chloride promoter; published data for this specific configuration is limited, but plant-scale runs have recorded a 3–5 % yield loss to the 6-hydroxy impurity, which is removed only by costly preparative HPLC chromatography on a C18 column with acetonitrile/water isocratic elution. A straightforward but operationally unforgiving entry into fluoroionophore construction for heavy-metal sensing relies on the inherent chelating donor set offered by the benzothiazole nitrogen, the 6-methoxy oxygen, and the 2-cyano group acting as a latent ligand after partial hydrolysis. Here, 2-cyano-6-methoxybenzothiazole is first refluxed in 6M HCl to generate the corresponding carboxylic acid, which is then coupled with a 2-aminothiophenol derivative in xylene under azeotropic water removal at 140 °C. The photoinduced electron transfer (PET) fluorophore thus obtained is doped at 10⁻⁴ mol/L into a plasticized PVC membrane formulated with o-nitrophenyl octyl ether as plasticizer, potassium tetrakis(4-chlorophenyl)borate as a lipophilic additive, and high-molecular-weight PVC. Membrane casting is performed on a polished glass ring set inside a controlled humidity glovebox at RH < 10 % because moisture ingress at the cocktail preparation stage creates microporosity that shortens the sensor lifetime from 90 days to fewer than 14 days under continuous exposure to 0.1M acetate background. Potentiometric selectivity coefficients (log Kpot determined according to the fixed interference method outlined in IUPAC Technical Report 2000) against sodium, potassium, and calcium are coherent only when the mole ratio of ionophore to borate additive is held at exactly 1:0.85; deviations toward a stoicihiometric 1:1 lead to anion interference that renders the sensor unusable in hard water matrices. The finished sensor film is installed into a flow-through cell in a portable heavy metal analyser deployed for field screening of cadmium in electroplating rinse water, with a limit of detection validated at 0.07 µg/L and a response time of <15 seconds. Condensation Monomer for Poly(Arylene Ether Benzothiazole) Dielectric InterlayersIncorporation of 2-cyano-6-methoxybenzothiazole into a high-temperature engineering thermoplastic begins with the conversion of the cyano group to a methyl ester via Pinner reaction with methanolic HCl, followed by a nucleophilic aromatic substitution polymerization with a bisphenol such as 4,4’-dihydroxybiphenyl in a sulfolane/toluene mixture at 190–200 °C. The resulting polymer, a poly(arylene ether benzothiazole) with a number-average molecular weight (Mn) targeted at 18,000–22,000 g/mol against polystyrene standards in THF, exhibits a glass transition temperature of 245 °C (DSC, 2nd heat, 20 °C/min, per ASTM D3418-21) and a dielectric constant of 2.8 at 1 GHz (ASTM D150-18). Such properties are exploited in the production of dry film solder mask and build-up dielectric layers for IC substrates, where the resin is formulated with a bismaleimide crosslinker (15 wt%), a phosphinate flame retardant, and fumed silica thixotrope (2.5 wt%) to yield a screen-printable ink. The viscosity is adjusted to 25,000–35,000 cP at 25 °C on a Brookfield RVDV-II+ spindle #6 and held stable for a pot life of 8 hours at 23 °C. Because the 6-methoxy substituent imparts a slight hydrophilicity to the cured matrix, pre-baking of the laminate at 120 °C for 2 hours and a vacuum hold at <1 mbar prior to coating becomes mandatory whenever the ambient relative humidity exceeds 60 %; omitting this step during monsoon season production runs in Southeast Asia correlates with an insulation resistance drop below the 10⁸ Ω threshold required by IPC-650, method 2.5.17.1, after 96 hours of moisture loading at 85 % RH/85 °C.
Suppressing Electrodeposition Edge Peeling by Pre-Treating the Steel Substrate with a Cyano-Methoxy Benzothiazole AdlayerA thin-film organic adhesion promoter for cathodic electrocoat on cold-rolled steel (CRS) bodies-in-white exploits the ability of the cyano and methoxy donor atoms to chemisorb onto metallic iron surfaces, forming a monomolecular blocking layer that delays underfilm corrosion propagation. The formulation is blended as a 0.25 % solution of 2-cyano-6-methoxybenzothiazole in a solvent mixture of di(propylene glycol) methyl ether and water (70:30 v/v), adjusted to pH 6.2 with acetic acid. CRS panels (Q-Panel R46, ground face) are dipped in this bath at 25 °C for 90 seconds, blown off with filtered compressed air, and immediately transferred to a cathodic epoxy deposition tank. The benzothiazole adlayer does not interfere with the deposition voltage, which is maintained at 220 V ramped over 15 seconds, but subsequent salt spray testing per ISO 9227:2022 (neutral salt spray, 1,000 h) reveals a distinctive failure mode when the coating thickness is below 18 µm: scribe creep width increases from the typical 2.5 mm to 6.0 mm if the benzothiazole treatment precedes a zinc phosphate conversion coating rather than replacing it. The root cause is a phosphatability blockage at low crystal density, documented in cross-sectional SEM-EDS as deficient hopeite formation. Consequently, processing on a full-scale automotive dipping line at 3.5 m/min line speed limits the use of this pre-treatment to areas where a phosphate layer is intentionally omitted—door hem flanges and enclosed box sections—and mandates a demineralized water rinse with conductivity below 30 µS/cm between stages to prevent benzothiazole drag-out into the phosphating bath. A divergent utilization profile opens within the domain of latent epoxy curing accelerators. When 2-cyano-6-methoxybenzothiazole is co-micronized with dicyandiamide at a weight ratio of 1:4 and dispersed in a bisphenol A diglycidyl ether resin (epoxy equivalent weight 188 g/eq), the onset of cure on a DSC thermogram (ASTM D3418-21, 10 °C/min) shifts from 178 °C for dicyandiamide alone down to 132 °C, creating a single-component system stable for 6 months at 25 °C but capable of gelling within 8 minutes at 160 °C. This reactivity profile suits the lamination of copper foil to a polyimide film in the manufacture of flexible printed circuits, where a slot-die coater lays down a 15 µm wet film that is B-staged in a vertical tower oven at 115 °C for 4 minutes. A persistent processing hazard arises from the volatility of the free 2-cyano-6-methoxybenzothiazole monomer: vapor condenses on the oven exhaust ductwork and crystallizes, creating a combustion risk upon oxidative cycling. Routine production procedures (aligned with OSHA 29 CFR 1910.1200 and NFPA 70E hazard assessments) therefore require that the B-stage oven be equipped with an automatic steam lance cleaning sequence every 72 operating hours and that the air flow rate be maintained at a minimum of 1.2 m/s through the exhaust plenum.
As a terminal application that places extreme demands on active substance purity, a chemiluminescent labelling reagent for acridinium ester-based immunoassays uses 2-cyano-6-methoxybenzothiazole as the activated ester leaving-group synthon. The transformation involves activation of the benzothiazole-2-carboxylic acid derivative to the N-hydroxysuccinimide (NHS) ester, which is then reacted with the primary amine of a monoclonal antibody specific to cardiac troponin I. The conjugation is carried out in a 0.1M sodium bicarbonate buffer at pH 8.3 containing 5 % DMF as co-solvent, at a molar challenge ratio of 15:1 (label:antibody). After quenching with Tris-HCl and purification on a PD-10 desalting column, the degree of labelling is determined by UV-Vis spectrophotometry and must fall between 3.5 and 5.0 labels per IgG. Batches falling outside this narrow window exhibit non-linear dose-response curves in the VIDAS® (bioMérieux) or Atellica® IM (Siemens Healthineers) clinical analyzers, classified as in-vitro diagnostic medical devices under In Vitro Diagnostic Medical Device Regulation (EU) 2017/746, Annex I, Chapter II. The light yield, measured as relative light units (RLU) on a GlobMax® 20/20 luminometer with an injection delay of 0.4 seconds, collapses entirely if the 2-cyano-6-methoxybenzothiazole lot contains any trace (>0.05 %) of the hydrolyzed benzothiazole-2-carboxylic acid, as the carboxylic acid competes for the activation site and generates non-luminescent side products. For this reason, the raw material is shipped under argon in amber glass bottles with Teflon-lined caps certified to United States Pharmacopeia |
Competitive 2-Cyano-6-Methoxybenzothiazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
2-Cyano-6-methoxybenzothiazole (C9H6N2OS, relative molecular mass 190.22 g mol⁻¹, CAS 330958-32-0) constitutes a difunctionalized benzothiazole scaffold in which an electron-withdrawing cyano group occupies the 2-position and an electron-donating methoxy group resides at the 6-position. The heterocycle is supplied as an off-white to pale yellow crystalline powder with a melting transition commonly observed between 129 °C and 132 °C (capillary method, USP 〈741〉). Commercial lots intended for synthetic building-block applications are typically certified to a purity of ≥98.0% by HPLC (UV detection at 254 nm, column C18, USP 〈621〉), with individual organic impurities capped at ≤0.5%. Moisture content, determined by Karl Fischer titration (USP 〈921〉), is held below 0.3% to prevent hydrolytic degradation of the cyano group during storage. The compound is soluble in common polar aprotic solvents (N,N-dimethylformamide, dimethyl sulfoxide, acetonitrile) and shows limited solubility in water (< 0.1 g L⁻¹ at 25 °C).
| Parameter | Specification | Test Method |
|---|---|---|
| Appearance | Off-white to pale yellow crystalline powder | Visual inspection |
| Purity (HPLC) | ≥ 98.0% | USP 〈621〉, C18, 254 nm |
| Melting range | 129–132 °C | USP 〈741〉, capillary |
| Moisture (KF) | ≤ 0.3% (w/w) | USP 〈921〉 |
| Residual solvents (GC-HS) | Ethanol ≤ 500 ppm; ethyl acetate ≤ 100 ppm | USP 〈467〉 |
| Heavy metals (ICP-MS) | Pb ≤ 10 ppm, Cd ≤ 5 ppm, As ≤ 2 ppm, Hg ≤ 1 ppm | USP 〈233〉 |
These release criteria align with pharmacopoeial monographs for analogous benzothiazole intermediates used in active pharmaceutical ingredient (API) GMP starting material supply chains. Lot-to-lot variability in the content of the des‑methoxy by‑product 2-cyanobenzothiazole, monitored at ≤ 0.1%, is controlled to prevent interference in subsequent regioselective transformations.
The table below contrasts reactivity profiles of closely related benzothiazole building blocks, highlighting the effect of the 2‑cyano/6‑methoxy pair on synthetic utility.
| Compound | 2‑Substituent | 6‑Substituent | Distinctive Reactivity Feature |
|---|---|---|---|
| 2-Cyano-6-methoxybenzothiazole | –CN (σm ≈ +0.56) | –OCH3 (σp ≈ −0.27) | Push‑pull electronic character; cyano enables tetrazole formation while methoxy activates ring for electrophilic substitution at C‑5 and C‑7 |
| 2‑Cyanobenzothiazole | –CN | –H | Weaker ring activation; nitration requires mixed acid at elevated temperature; no handle for late‑stage O‑demethylation |
| 6‑Methoxybenzothiazole | –H | –OCH3 | Lacks the synthetic versatility of the 2‑cyano group; cannot be converted to amidine or tetrazole pharmacophores |
| 2‑Amino-6-methoxybenzothiazole | –NH2 | –OCH3 | NH2 limits coupling options; Sandmeyer chemistry needed to install cyano, reducing overall yield and increasing waste load |
| 2‑Bromo-6-methoxybenzothiazole | –Br | –OCH3 | Excellent for Pd‑catalyzed cross‑couplings but prone to debromination under reductive conditions; cyano group not present for further elaboration |
The combination of the 2‑cyano and 6‑methoxy substituents allows sequential or orthogonal derivatization without deprotection steps—a clear advantage over mono‑functional analogues. The methoxy group can be demethylated to a phenol using BBr3 (CH2Cl2, −78 °C to 0 °C, quench with MeOH) while leaving the cyano group intact, enabling water‑soluble salt formation or conjugation.
In palladium‑mediated transformations, this electronic dichotomy introduces a processing boundary. During attempted Suzuki–Miyaura couplings using 5‑bromo‑2‑cyano‑6‑methoxybenzothiazole as electrophile, the 2‑cyano group can coordinate Pd0, competing with the phosphine ligand and retarding oxidative addition. On a 50 L glass‑lined reactor (Hastelloy C‑22) equipped with a retreat‑blade impeller, catalyst activation experiments demonstrated that a Pd2(dba)3/SPhos pre‑catalyst (0.5 mol% Pd, SPhos/Pd = 2.2) required a 30‑minute pre‑stir at 45 °C in THF before addition of the boronic acid and base (K3PO4·H2O) to decrease induction periods from > 4 h to < 40 min. Without this pre‑ligation step, the reaction mass turned deep green—indicative of cyano‑bridged polynuclear Pd species—and gave a product yield below 22% (HPLC area).
Cross‑coupling at the 5‑position of 2‑cyano‑6‑methoxybenzothiazole itself (as an unhalogenated scaffold) is typically routed through C–H activation. Using 2‑arylated benzothiazole syntheses catalyzed by Pd(OAc)2 with PivOH and Ag2CO3, the methoxy group directs palladation selectively to C‑5, while the cyano at C‑2 remains unreactive. However, published data for this specific configuration indicate that co‑solvent selection (DMF/t‑BuOH 3:1 v/v) is critical; trace water (>0.1%) promotes cyanide hydrolysis and subsequent catalyst poisoning by amide, dropping isolated yields from 71% to 34%. When oxygen levels in the headspace exceeded 5000 ppm during degassing cycles, homocoupling of the boronic acid became dominant, underscoring the need for oxygen content below 200 ppm (monitored by in‑line paramagnetic analyzer).
The 6‑methoxy substituent serves as a potent directing group for lithiation at the adjacent C‑7 position, whereas the 2‑cyano group can likewise coordinate lithium amide bases, creating a competitive manifold. Pilot‑scale campaigns (reaction calorimeter, Mettler Toledo RC1e) with lithium diisopropylamide (LDA, 1.05 equiv) in anhydrous THF established an operational window of −78 ± 5 °C. At temperatures above −73 °C, deprotonation at the cyano‑adjacent position (C‑3) and subsequent ring‑opening of the thiazole became detectable by LC‑MS as two new impurities with m/z [M+H]+ = 241 and 257, respectively. Below −83 °C, the rate of lithiation dropped substantially, requiring extended aging (>60 min) that led to partial decomposition of the lithio species, reflected in a drop of quench‑captured yield from 78% to 51%.
Addition rate of LDA proved to be the dominant process parameter. Using a peristaltic dosing pump (Ismatec Reglo ICC) to deliver LDA over 40 minutes into a 20 L jacketed vessel maintained a local ΔT below 3 °C, minimizing byproduct formation. Under these conditions, quenching with iodomethane (1.2 equiv) gave 2‑cyano‑6‑methoxy‑7‑methylbenzothiazole in 73% isolated yield after silica gel chromatography (gradient hexane/EtOAc). Substituting with N‑fluorobenzenesulfonimide introduced a fluorine atom at C‑7 (yield 68%), demonstrating the breadth of electrophile scope. In all cases, the cyano group remained intact, confirmed by the presence of the characteristic νCN stretch at 2232 cm⁻¹ (ATR‑FTIR) in the purified product.
The compound also functions as a key intermediate in medicinal chemistry programs targeting kinase inhibition. 2‑Cyano‑6‑methoxybenzothiazole is converted to the corresponding thioamide (H2S/Et3N, pyridine, 60 °C) and subsequently cyclized to a 1,2,4‑thiadiazole in one pot, with a process mass intensity (PMI) of 38 on a 5 kg scale. The methoxy group at the 6‑position provides a site for late‑stage diversification via O‑demethylation and Mitsunobu coupling without disturbing the heterocyclic core, a sequence not readily executed on the 2‑amino or 2‑bromo counterparts without protection–deprotection cycles. Residual palladium content in API synthesized through this route is controlled to ≤ 1 ppm (ICP‑MS) by a charcoal‑filtration step validated per ICH Q3D.
Storage stability assessments under ICH Q1A(R2) conditions indicate that 2‑cyano‑6‑methoxybenzothiazole should be kept in airtight containers under nitrogen at −20 °C to 4 °C; exposure to relative humidity above 60% for 48 h results in a purity decrease of 0.8–1.2% due to slow hydration of the cyano group. Compatibility testing has shown that direct blending with amine‑based additives (e.g., triethylamine, DBU) accelerates dimerization at ambient temperature, forming a bis‑benzothiazole impurity identified by 1H‑NMR; therefore neutral or slightly acidic matrices are recommended for formulation work.